Historique
Auteur J. GREBELY
Documents disponibles écrits par cet auteur (38)
Ajouter le résultat à votre sélection Affiner la recherche
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT | 2023
Dans Addiction (Vol.118, n°9, September 2023) Article : PériodiqueBACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]
M. ALAVI ; J. GREBELY ; M. MICALLEF ; A. J. DUNLOP ; A. C. BALCOMB ; C. A. DAY ; C. TRELOAR ; N. BATH ; P. S. HABER ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : PériodiqueBACKGROUND: Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic [...]
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : PériodiqueBACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]
R. SACKS-DAVIS ; D. HORYNIAK ; J. GREBELY ; M. HELLARD | 2012
Dans International Journal of Drug Policy (Vol.23, n°3, May 2012) Article : PériodiqueBACKGROUND: A systematic review was conducted to determine whether behavioural interventions are effective in preventing transmission of hepatitis C virus (HCV) amongst people who inject drugs. METHODS: Medline, EMBASE, the Cochrane Clinical T[...]![Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs [Commentary]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=76282)
S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT | 2015
Dans International Journal of Drug Policy (Vol.26, n°10, October 2015) Article : PériodiqueThere is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]
E. ASPINALL ; A. WEIR ; R. SACKS-DAVIS ; T. SPELMAN ; J. GREBELY ; P. HIGGS ; S. J. HUTCHINSON ; M. E. HELLARD | 2014
Dans International Journal of Drug Policy (Vol.25, n°1, January 2014) Article : PériodiqueBACKGROUND: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this [...]
J. GREBELY ; G. J. DORE ; S. MORIN ; J. K. ROCKSTROH ; M. B. KLEIN | 2017
Dans Journal of the International AIDS Society (Vol.20, n°22146, August 2017) Article : PériodiqueINTRODUCTION: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverag[...]
J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : PériodiqueThere have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017
Bulletin : Périodique
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : PériodiqueBACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT | 2017
Dans BMC Public Health (Vol.17, n°757, 2017) Article : PériodiqueBackground: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]
International Journal of Drug Policy, Vol.26, n°10 - October 2015 - Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015
Bulletin : Périodique![Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs [Editorial]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=76280)
J. GREBELY ; P. BRUGGMANN ; C. TRELOAR ; J. BYRNE ; T. RHODES ; G. J. DORE | 2015
Dans International Journal of Drug Policy (Vol.26, n°10, October 2015) Article : Périodique
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT | 2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : PériodiqueBACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : PériodiqueBACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]
